细胞分离市场规模、份额和成长分析(按产品类型、细胞类型、细胞来源、技术、应用和地区划分)—2026-2033年产业预测
市场调查报告书
商品编码
1899890

细胞分离市场规模、份额和成长分析(按产品类型、细胞类型、细胞来源、技术、应用和地区划分)—2026-2033年产业预测

Cell Isolation Market Size, Share, and Growth Analysis, By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Cell Source, By Technique, By Application, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 188 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年,细胞分离市场规模将达到 53.5 亿美元,到 2025 年将达到 60.3 亿美元,到 2033 年将达到 158.1 亿美元,在预测期(2026-2033 年)内,复合年增长率为 12.8%。

细胞分离技术对于包括生物製药开发、治疗性蛋白质合成和研究分析在内的众多应用至关重要。慢性疾病导致的医疗保健成本不断攀升,以及政府推动生物技术发展的倡议,正推动对先进细胞分离技术的需求激增。 NanoString Technologies、Levitas Bio 和 Bionano Genomics 等公司正在扩展其生产流程和产品线以满足此需求。近期技术进步使得针对特定应用筛选高性能细胞成为可能,有助于提升研究成果。生物製药的兴起和对医疗创新日益增长的关注,反映了旨在优化研究和治疗方法的市场趋势,进一步推动了对先进细胞分离设备的需求。这一趋势为该领域带来了强劲的成长机会。

细胞分离市场驱动因素

细胞分离市场的发展主要受慢性疾病(尤其是癌症)发生率上升的推动。全球癌症发生率的不断攀升,导致对创新研究和治疗方案的需求日益增长。细胞分离技术在癌症研究中至关重要,它使科学家能够分析不同类型的细胞,从而促进标靶治疗和个人化医疗的开发。细胞分离技术使研究人员能够深入了解肿瘤生物学、抗药性和免疫反应,进而设计出更有效的治疗方法。此外,对包括免疫疗法在内的先进治疗方法的需求不断增长,也进一步推动了对细胞分离技术的需求,进而促进了研究机构、生物技术和製药公司的发展和创新。

限制细胞分离市场发展的因素

细胞分离市场面临的主要挑战之一是,分离特定细胞类型所需的专用设备和技术需要大量的资金投入。流式细胞仪、离心机和磁激活细胞分选(MACS)系统等先进工具的高成本,使得许多小规模研究机构和实验室难以采用。此外,试剂的持续支出以及对高素质人员的需求,都会增加整体经济负担,从而可能阻碍先进细胞分离方法的应用,并限制该领域的研发机会。

细胞分离市场趋势

细胞分离市场正经历着向微流控技术大规模应用的重大转变。此技术透过微小通道操控微量流体,能够根据细胞的大小和形状等独特属性进行精确分离。这显着提高了从复杂生物基质中分离稀有细胞类型(包括循环性肿瘤细胞和干细胞)的效率。微流体技术具有精度和效率更高、试剂消费量更少、成本效益高等优势,使其成为科学研究和临床应用领域极具吸引力的解决方案,并推动其在医疗和生物技术领域的广泛应用。

目录

介绍

  • 调查目标
  • 定义
  • 市场覆盖范围

调查方法

  • 资讯收集
  • 二手和一手资讯来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

    前景
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场动态
    • 司机
    • 机会
    • 抑制因素
    • 任务
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 技术分析
  • 定价分析
  • 价值链分析
  • 专利分析
  • 供应链分析
  • 监管环境
  • 客户和购买标准分析

细胞分离市场:依产品分类

  • 消耗品
    • 试剂、试剂盒、培养基及血清
    • 磁珠
    • 萤光珠
    • 一次性产品
  • 装置
    • 离心机
    • 细胞分选装置
    • 磁激活细胞分离系统
    • 过滤系统

按细胞类型分類的细胞分离市场

  • 人类细胞
    • 分化细胞
    • 干细胞
  • 动物细胞

细胞分离市场:依细胞来源划分

  • 脂肪组织
  • 骨髓
  • 脐带血/胚胎干细胞
  • 其他细胞来源

细胞分离市场:依技术划分

  • 离心分离细胞
  • 基于表面标誌物的细胞分离
  • 透过过滤进行细胞分离。

细胞分离市场:依应用领域划分

  • 生物分子分离
  • 癌症研究
  • 干细胞研究
  • 组织再生与再生医学
  • 体外诊断
  • 其他用途

按最终用户分類的细胞分离市场

  • 製药和生物技术公司
  • 学术和研究机构
  • 医院和诊断检查室
  • 其他最终用户

细胞分离市场规模:依地区划分

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲(MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争格局

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市占率(2025 年)

主要企业简介

  • Danaher Corporation(US)
  • Merck KGAA(Germany)
  • Thermo Fisher Scientific Inc.(US)
  • BD(Becton, Dickinson and Company)(US)
  • Sartorius AG(Germany)
  • Agilent Technologies, Inc.(US)
  • Bio-Rad Laboratories, Inc.(US)
  • Qiagen(Netherlands)
  • F. Hoffmann-La Roche Ltd.(Switzerland)
  • Revvity(US)
  • Lonza(Switzerland)
  • Bio-Techne(US)
  • Terumo Corporation(Japan)
  • Miltenyi Biotec(Germany)
  • Takara Bio Inc.(Japan)
  • Genscript(China)
  • Standard Biotools(US)
  • Alfa Laval(Sweden)
  • Promega Corporation(US)
  • Cell Signaling Technology, Inc.(US)
  • Micareo Inc.(US)
  • Applied Cells Inc.(US)
  • Stemcell Technologies(Canada)
  • Creative Bioarray(US)
  • Proteintech Group, Inc.(US)
  • Magbio Genomics, Inc.(US)
  • Akadeum Life Sciences(US)
  • Pluriselect Life Science Ug(Haftungsbeschrankt)& Co. KG(Germany)
  • Invent Biotechnologies, Inc.(US)
简介目录
Product Code: SQMIG35H2298

Cell Isolation Market size was valued at USD 5.35 Billion in 2024 and is poised to grow from USD 6.03 Billion in 2025 to USD 15.81 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

Cell isolation is pivotal across a spectrum of applications, including biologics development, therapeutic protein synthesis, and research analysis. As healthcare costs rise due to chronic diseases, coupled with government initiatives aimed at boosting biotechnology, the demand for advanced cell isolation techniques is surging. Companies like NanoString Technologies, Levitas Bio, and Bionano Genomics have expanded their manufacturing processes and product lines to meet this demand. Recent innovations allow for the selection of high-performing cells for targeted applications, enhancing research outcomes. The rise of biopharmaceuticals and increased focus on healthcare innovation further drive the need for advanced cell isolation equipment, reflecting a growing trend in the market that seeks to optimize research and treatment methodologies. This trend indicates a robust opportunity for growth within the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Isolation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Isolation Market Segments Analysis

Global Cell Isolation Market is segmented by Product, Cell Type, Cell Source, Technique, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Cell Type, the market is segmented into Human Cells, and Animal Cells. Based on Cell Source, the market is segmented into Adipose Tissue, Bone Marrow, Cord Blood/Embryonic Stem Cells, and Other Cell Sources. Based on Technique, the market is segmented into Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, and Filtration-Based Cell Isolation. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research,Stem CellResearch, Tissue, Regeneration & Regenerative Medicine, In Vitro Diagnostics, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cell Isolation Market

The cell isolation market is significantly driven by the rising incidence of chronic diseases, particularly cancer. As cancer rates escalate globally, the need for innovative research and treatment solutions intensifies. Cell isolation is crucial in cancer research, allowing scientists to examine distinct cell types, which facilitates the creation of targeted therapies and personalized medicine. By isolating cells, researchers gain vital insights into tumor biology, drug resistance, and immune responses, leading to the design of more effective treatments. Additionally, the growing demand for advanced therapies, including immunotherapy, further fuels the need for cell isolation techniques, driving growth and innovation across research institutions, biotech firms, and pharmaceutical companies.

Restraints in the Cell Isolation Market

One of the primary challenges facing the cell isolation market is the significant financial investment required for the specialized equipment and technologies necessary for isolating specific cell types. The high costs associated with advanced tools like flow cytometers, centrifuges, and magnetic-activated cell sorting (MACS) systems can deter many small research institutions and laboratories from acquiring them. Additionally, the ongoing expenses for reagents and the need for highly trained personnel further contribute to the overall financial strain, which may hinder the adoption of sophisticated cell isolation methods and limit research and development opportunities in this field.

Market Trends of the Cell Isolation Market

The cell isolation market is witnessing a significant shift towards the large-scale application of microfluidics technology, characterized by the manipulation of tiny fluid volumes through microchannels. This innovative approach allows for the precise separation of cells based on distinct characteristics such as size and shape, enhancing the isolation of rare cell types from complex biological matrices, including circulating tumor cells and stem cells. The advantages of microfluidics, including improved accuracy and efficiency, coupled with reduced reagent consumption and cost-effectiveness, position it as a highly attractive solution for both research and clinical applications, thereby driving its adoption across the healthcare and biotechnology sectors.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Technology Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • Patent Analysis
  • Supply Chain Analysis
  • Regulatory Landscape
  • Customer & Buying Criteria Analysis

Cell Isolation Market by Product

  • Market Overview
  • Consumables
    • Reagents, Kits, Media, And Sera
    • Beads
    • Magnetic Beads
    • Fluorescent Beads
    • Disposables
  • Instruments
    • Centrifuges
    • Cell Sorters
    • Magnetic-Activated Cell Separator Systems
    • Filtration Systems

Cell Isolation Market by Cell Type

  • Market Overview
  • Human Cells
    • Differentiated Cells
    • Stem Cells
  • Animal Cells

Cell Isolation Market by Cell Source

  • Market Overview
  • Adipose Tissue
  • Bone Marrow
  • Cord Blood/Embryonic Stem Cells
  • Other Cell Sources

Cell Isolation Market by Technique

  • Market Overview
  • Centrifugation-Based Cell Isolation
  • Surface Marker-Based Cell Isolation
  • Filtration-Based Cell Isolation

Cell Isolation Market by Application

  • Market Overview
  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • Tissue Regeneration & Regenerative Medicine
  • In Vitro Diagnostics
  • Other Applications

Cell Isolation Market by End User

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Diagnostic Laboratories
  • Other End Users

Cell Isolation Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2025

Key Company Profiles

  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGAA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD (Becton, Dickinson and Company) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Techne (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Miltenyi Biotec (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genscript (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Standard Biotools (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alfa Laval (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cell Signaling Technology, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Micareo Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Applied Cells Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stemcell Technologies (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Bioarray (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteintech Group, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Magbio Genomics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Akadeum Life Sciences (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pluriselect Life Science Ug (Haftungsbeschrankt) & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Invent Biotechnologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments